Increased LC3 expression typically has unfavorable results in lung and pancreatic cancers and melanoma [30,34], while decreased LC3 expression has been correlated with tumorigenesis and a poor prognosis in breast cancer and early stage cervical squamous cell carcinoma [20,33]. The gene discussed is MAP1LC3A; the disease is melanoma.